A non-irritation, non-blurring, photostable ophthalmic sunscreen composition contains at least one of the following: bemotrizinol; bisoctrizole; tris-biphenyl triazine; and/or octyl methoxycinnamate. A liquid vehicle base is then a remainder of the solution by weight. The composition is an artificial tear formulation or an ophthalmic suspension or ointment. The composition may include at least one inorganic and/or at least one organic active ingredient. The inorganic active ingredients may include, but not be limited to zinc oxide, titanium dioxide, iron oxide, zirconium oxide, and cerium oxide. The organic active ingredients may include, but not be limited to dioxybenzone, octinoxate, octisalate, homosalate, avobenzone, octocrylene, para-aminobenzoic acid, cinoxate, methyl anthranilate, octocrylene, padimate O, ensulizole, sulisobenzone, trolamine salicylate, and ecamsule.

This invention relates to a hair care composition more particularly to a wash-off composition, especially preferred being a shampoo or a conditioner, which provides the desired anti-dandruff efficacy with enhanced stability of the active materials on hair/scalp during use. This is achieved through a judicious combination of an organic UV filter, a zinc compound and selective anti-dandruff agent. The composition comprises 0.01 to 3% by weight zinc pyrithione, an organic UV filter and 0.1 to 5% by weight additional zinc compound. The weight ratio of zinc compound to zinc pyrithione is over 3:1.

The present invention relates to cosmetic compositions having antioxidant properties and suitable for any type of skin.

The present invention relates to a compound represented by the following formula (I): A[B—(C).sub.v].sub.w, wherein A is a photoprotective moiety, B is a linker, C is a functional group, v is an integer from 1 to 2000, and w is an integer from 1 to 6. It also relates to a composition comprising the same and, more particularly, to a cosmetic or a sunscreen composition. It also relates to the use of such compounds in cosmetic and therapeutic applications. The invention also relates to the use of such compounds for reducing photodegradation and/or photoinstability of pharmaceuticals and cosmetics. The invention further relates to a material comprising a support and such a compound adhered to said support.

The present invention provides three embodiments to create and apply a tattoo to a dermal area of a recipient wherein the tattoo is non-permanent. The present invention includes a first embodiment and a second embodiment wherein the tattoo ink is removable via introduction of a solution and/or a solvent. A third embodiment of the present invention provides a method for tattoo ink creation that provides a tattoo ink that will degrade within the aqueous bodily environment over a period of time based on the polymer with which the water soluble dye is created. The first embodiment utilizes an organic dye that contains at least one metal atom. A solution containing a chelating agent is presented to the tattooed area wherein the chelating agent will extract the metal atom resulting in disappearance of the tattoo ink. Another embodiment utilizes wax encapsulated ink to be removed by presentation of a solvent.

Provided are an ultraviolet (UV)-blocking cosmetic composition which is dispersed in water and is free of oil and a method of preparing the same. Since the composition does not contain oil, skin trouble may not occur, and since the composition does not include a surfactant, spreadability and feeling of use are excellent. In addition, cloudiness phenomenon or skin greasiness does not occur during use, and the UV-blocking effects are excellent.

Compositions and formulations for hair treatment are provided herein. Methods for hair treatment, such as methods for preventing or treating hair loss or hair thinning, are also provided herein. The methods may promote hair growth, hair restoration or hair thickening, or increase hair density or hair growth rate.

The present invention relates to the use of methylene bis-benzotriazolyl tetramethylbutylphenol, optionally in combination with tris-biphenyl triazine, to reduce fabric staining of a sunscreen or daily care composition, wherein the sunscreen or daily care composition comprises (i) at least one particulate UV-f liter; and/or (ii) at least one oil soluble UV-A filter, wherein the at least one oil soluble UV-A filter is present in an amount of at most 3% by weight, based on the total weight of the sunscreen or daily care composition; and/or (iii) at least one water soluble UV filter. Furthermore, the present invention relates to the use of methylene bis-benzotriazolyl tetramethylbutylphenol, optionally in combination with tris-biphenyl triazine, to facilitate the washability of such sunscreen or daily care compositions from textiles.

Methods and compositions for treating disorders of the nail and nail bed. Such compositions contain a vehicle in which all components of the composition are dissolved, suspended, dispersed, or emulsified, a non-volatile solvent, a wetting agent, and a pharmaceutically active ingredient that is soluble in the non-volatile solvent and/or a mixture of the vehicle and the non-volatile solvent, and which composition is effective in treating a disorder of the nail or nail bed.

A non-irritation, non-blurring, photostable ophthalmic sunscreen composition contains at least one of the following: bemotrizinol; bisoctrizole; tris-biphenyl triazine; and/or octyl methoxycinnamate. A liquid vehicle base is then a remainder of the solution by weight. The composition is an artificial tear formulation or an ophthalmic suspension or ointment. The composition may include at least one inorganic and/or at least one organic active ingredient. The inorganic active ingredients may include, but not be limited to zinc oxide, titanium dioxide, iron oxide, zirconium oxide, and cerium oxide. The organic active ingredients may include, but not be limited to dioxybenzone, octinoxate, octisalate, homosalate, avobenzone, octocrylene, para-aminobenzoic acid, cinoxate, methyl anthranilate, octocrylene, padimate O, ensulizole, sulisobenzone, trolamine salicylate, and ecamsule.